Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others ...

Researchers from the University of Utah identified a component within the venom that acts like somatostatin, a human hormone ...

Growth hormone levels decreased from 13.5 ± 3.1 ... The authors concluded that long-term treatment with somatostatin analogs is effective and well tolerated.

One hormone that could serve this function is somatostatin, which acts as a brake to prevent blood sugar from rising to normal levels. Blood glucose levels are mainly regulated by the opposing actions ...

Lanreotide, the active component of Somatuline Depot is an octapeptide analog of natural somatostatin. The mechanism of action of lanreotide is believed to be similar to that of natural somatostatin.

Pasireotide, a new panreceptor analog, might control clinical symptoms and hormone release in patients resistant to standard somatostatin analog therapy. mTOR and tyrosine kinase inhibitors may ...